Kreike Bas, Halfwerk Hans, Kristel Petra, Glas Annuska, Peterse Hans, Bartelink Harry, van de Vijver Marc J
Department of Radiation Oncology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands.
Clin Cancer Res. 2006 Oct 1;12(19):5705-12. doi: 10.1158/1078-0432.CCR-06-0805.
Several risk factors for local recurrence of breast cancer after breast-conserving therapy (BCT) have been identified. The identification of additional risk factors would be very useful in guiding optimal therapy and also in improving understanding of the mechanisms underlying local recurrence. We used cDNA microarray analysis to identify gene expression profiles associated with local recurrence.
Using 18K cDNA microarrays, gene expression profiles were obtained from 50 patients who underwent BCT. Of these 50 patients, 19 developed a local recurrence; the remaining 31 patients were selected as controls as they were free of local recurrence at least 11 years after treatment. For 9 of 19 patients, the local recurrence was also available for gene expression profiling. Unsupervised and supervised methods of classification were used to separate patients in groups corresponding to disease outcome and to study the overall gene expression pattern of primary tumors and their recurrences.
Hierarchical clustering of patients did not show any grouping reflecting local recurrence status. Supervised analysis revealed no significant set of genes that was able to distinguish recurring tumors from nonrecurring tumors. Paired-data analysis of primary tumors and local recurrences showed a remarkable similarity in gene expression profile between primary tumors and their recurrences.
No significant differences in gene expression between primary breast cancer tumors in patients with or without local recurrence after BCT were identified. Furthermore, analyses of primary tumors and local recurrences show a preservation of the overall gene expression pattern in the local recurrence, even after radiotherapy.
已确定了保乳治疗(BCT)后乳腺癌局部复发的若干风险因素。识别其他风险因素对于指导最佳治疗以及增进对局部复发潜在机制的理解非常有用。我们使用cDNA微阵列分析来识别与局部复发相关的基因表达谱。
使用18K cDNA微阵列,从50例行BCT的患者中获取基因表达谱。在这50例患者中,19例发生了局部复发;其余31例患者被选为对照组,因为他们在治疗后至少11年无局部复发。在19例患者中的9例中,局部复发组织也可用于基因表达谱分析。采用无监督和有监督的分类方法将患者分为与疾病结局对应的组,以研究原发肿瘤及其复发的总体基因表达模式。
患者的层次聚类未显示出任何反映局部复发状态的分组。有监督分析未发现能区分复发肿瘤与未复发肿瘤的显著基因集。原发肿瘤与局部复发的配对数据分析显示,原发肿瘤与其复发之间在基因表达谱上有显著相似性。
未发现BCT后有或无局部复发患者的原发性乳腺癌肿瘤之间在基因表达上有显著差异。此外,对原发肿瘤和局部复发的分析表明,即使经过放疗,局部复发中总体基因表达模式仍得以保留。